Abiopharma

New Form SCHEDULE 13G - Maywood Acquisition Corp. 2 <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005323 <b>Size:</b> 9 KB

Trinity Biotech Secures Additional $7.0 Million Investment from Perceptive Advisors and Regains Compliance with Nasdaq Minimum Bid Price Requirement

New Form SCHEDULE 13G/A - BEL FUSE INC /NJ <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005319 <b>Size:</b> 8 KB

New Form SCHEDULE 13G/A - METHANEX CORP <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005320 <b>Size:</b> 9 KB

New Form SCHEDULE 13G/A - WW INTERNATIONAL, INC. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001512162-26-000023 <b>Size:</b> 7 KB

New Form SCHEDULE 13G - Sharplink, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005315 <b>Size:</b> 11 KB

New Form SCHEDULE 13G - TOYO Co., Ltd <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005318 <b>Size:</b> 9 KB

New Form SCHEDULE 13G/A - PEABODY ENERGY CORP <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005316 <b>Size:</b> 10 KB

New Form SCHEDULE 13G/A - Aspire Biopharma Holdings, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005317 <b>Size:</b> 9 KB

PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q2 2026 Results and Files Form 10-Q; Total Assets Reach $36.6 Million, Up 184% from Year-End 2025 and 290% Year-over-Year, as Quarterly Revenue Nearly Doubles Sequentially

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001193125-26-351387 <b>Size:</b> 227 KB

New Form SCHEDULE 13G/A - Nine Energy Service, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000935836-26-000409 <b>Size:</b> 20 KB

Le CN poursuit ses innovations en matière de locomotives

Cadiz Issues Q2 2026 Letter to Shareholders

CN Continues to Advance Locomotive Innovations